Pyrazolo-[3,4-g]isoquinoline derivatives useful to treat CNS dis

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

546 82, A61K 3147, C07D48904

Patent

active

049635581

ABSTRACT:
Pharmaceutical compounds of the formula ##STR1## in which R.sup.1 is hydrogen or C.sub.1-6 alkyl, R.sup.2 is hydrogen, C.sub.1-6 alkyl optionally substituted by C.sub.3-9 cycloalkyl or optionally substituted phenyl, C.sub.3-9 cycloalkyl, optionally substituted phenyl, or --SR.sup.4 where R.sup.4 is C.sub.1-6 alkyl optionally substituted by C.sub.3-9 cycloalkyl or optionally substituted phenyl, or C.sub.3-9 cycloalkyl, R.sup.3 is hydrogen, C.sub.1-6 alkyl optionally substituted by C.sub.3-9 cycloalkyl or optionally substituted phenyl, c.sub.3-9 cycloalkyl, or optionally phenyl, and either X and Y are both hydrogen or together are .dbd.O; and acid addition salts thereof. These compounds show useful effects on the central nervous system.

REFERENCES:
patent: 4230861 (1980-10-01), Kornfeld et al.
patent: 4468401 (1984-08-01), Hahn
patent: 4596871 (1986-06-01), Schaus et al.
patent: 4762843 (1988-08-01), Caprathe et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Pyrazolo-[3,4-g]isoquinoline derivatives useful to treat CNS dis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrazolo-[3,4-g]isoquinoline derivatives useful to treat CNS dis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazolo-[3,4-g]isoquinoline derivatives useful to treat CNS dis will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-850079

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.